X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23565) 23565
Newsletter (469) 469
Newspaper Article (158) 158
Book Chapter (133) 133
Magazine Article (76) 76
Dissertation (17) 17
Publication (8) 8
Transcript (7) 7
Conference Proceeding (5) 5
Streaming Video (3) 3
Web Resource (3) 3
Book / eBook (2) 2
Book Review (2) 2
Reference (2) 2
Report (2) 2
Trade Publication Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18880) 18880
methotrexate - administration & dosage (14015) 14015
female (12833) 12833
science & technology (12682) 12682
life sciences & biomedicine (12369) 12369
male (10163) 10163
methotrexate (9663) 9663
adult (8026) 8026
middle aged (7919) 7919
methotrexate - therapeutic use (5917) 5917
antineoplastic combined chemotherapy protocols - therapeutic use (5840) 5840
aged (5416) 5416
methotrexate - adverse effects (4260) 4260
treatment outcome (3945) 3945
oncology (3889) 3889
cyclophosphamide - administration & dosage (3666) 3666
adolescent (3338) 3338
drug therapy, combination (3111) 3111
child (2992) 2992
abridged index medicus (2792) 2792
doxorubicin - administration & dosage (2740) 2740
animals (2683) 2683
rheumatoid arthritis (2649) 2649
arthritis, rheumatoid - drug therapy (2567) 2567
vincristine - administration & dosage (2484) 2484
fluorouracil - administration & dosage (2429) 2429
rheumatology (2375) 2375
drug administration schedule (2214) 2214
combined modality therapy (2107) 2107
chemotherapy (2101) 2101
care and treatment (1931) 1931
child, preschool (1892) 1892
cisplatin - administration & dosage (1888) 1888
prognosis (1804) 1804
retrospective studies (1766) 1766
time factors (1766) 1766
antineoplastic combined chemotherapy protocols - adverse effects (1753) 1753
breast neoplasms - drug therapy (1709) 1709
follow-up studies (1707) 1707
pharmacology & pharmacy (1649) 1649
pregnancy (1634) 1634
hematology (1618) 1618
dosage and administration (1612) 1612
cancer (1610) 1610
drug therapy (1595) 1595
antineoplastic combined chemotherapy protocols - administration & dosage (1580) 1580
dose-response relationship, drug (1568) 1568
antirheumatic agents - therapeutic use (1524) 1524
prednisone - administration & dosage (1454) 1454
research (1406) 1406
remission induction (1377) 1377
medicine & public health (1319) 1319
antirheumatic agents - administration & dosage (1300) 1300
methotrexate - pharmacology (1267) 1267
cytarabine - administration & dosage (1209) 1209
risk factors (1186) 1186
leucovorin - administration & dosage (1185) 1185
antineoplastic agents - administration & dosage (1157) 1157
prospective studies (1119) 1119
patients (1097) 1097
arthritis (1080) 1080
analysis (1072) 1072
mice (1046) 1046
rats (1026) 1026
survival rate (1017) 1017
immunosuppressive agents - therapeutic use (1006) 1006
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1006) 1006
etoposide - administration & dosage (1003) 1003
antimetabolites, antineoplastic - administration & dosage (993) 993
health aspects (988) 988
bleomycin - administration & dosage (986) 986
disease-free survival (980) 980
dermatology (973) 973
pediatrics (970) 970
administration, oral (959) 959
infant (948) 948
clinical trials as topic (926) 926
aged, 80 and over (915) 915
neoplasm staging (906) 906
antirheumatic agents - adverse effects (897) 897
chemotherapy, adjuvant (897) 897
rheumatoid factor (875) 875
young adult (875) 875
methotrexate - pharmacokinetics (855) 855
obstetrics & gynecology (854) 854
survival analysis (853) 853
vinblastine - administration & dosage (810) 810
immunosuppressive agents - administration & dosage (795) 795
injections, spinal (793) 793
severity of illness index (765) 765
immunology (763) 763
psoriasis - drug therapy (762) 762
cyclophosphamide - therapeutic use (723) 723
general & internal medicine (709) 709
breast neoplasms - pathology (706) 706
breast cancer (698) 698
medicine, general & internal (686) 686
psoriasis (686) 686
clinical trials (668) 668
recurrence (657) 657
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22112) 22112
Japanese (948) 948
German (578) 578
French (432) 432
Russian (269) 269
Spanish (203) 203
Chinese (169) 169
Polish (162) 162
Italian (143) 143
Portuguese (47) 47
Hungarian (36) 36
Dutch (30) 30
Danish (23) 23
Korean (22) 22
Czech (18) 18
Norwegian (16) 16
Hebrew (15) 15
Bulgarian (12) 12
Swedish (9) 9
Croatian (7) 7
Romanian (5) 5
Finnish (4) 4
Serbian (4) 4
Turkish (4) 4
Persian (3) 3
Arabic (2) 2
Lithuanian (2) 2
Slovak (2) 2
Estonian (1) 1
Greek (1) 1
Kurdish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 06/2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2014, Volume 370, Issue 25, pp. 2377 - 2386
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Summary Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Chemotherapy | Databases | Cytogenetics | Cancer therapies | Cancer | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
by Fleischmann, Roy and Mysler, Eduardo and Hall, Stephen and Kivitz, Alan J and Moots, Robert J and Luo, Zhen and DeMasi, Ryan and Soma, Koshika and Zhang, Richard and Takiya, Liza and Tatulych, Svitlana and Mojcik, Christopher and Krishnaswami, Sriram and Menon, Sujatha and Smolen, Josef S and Adams, Luthando and Ally, Mahmood M and du Plooy, Maria C and Louw, Ingrid C and Nayiager, Savithree and Nel, Christoffel B and Nel, Debra and Reuter, Helmuth and Soloman, Ahmed S and Spargo, Catherine E and Rischmueller, Maureen and Sharma, Shunil D and Will, Robert K and Youssef, Peter P and Arroyo, Caroline and Baes, Rosario P and Dulos, Roger B and Hao, Llewellyn T and Lanzon, Allan E and Lichauco, Juan Javier T and Mangubat, Jill H and Ramiterre, Edgar B and Reyes, Bernadette Heizel M and Tan, Perry P and Choe, Jung-Yoon and Kang, Young Mo and Kwon, Seong Ryul and Lee, Sang-Heon and Lee, Shin-Seok and Yoo, Dae-Hyun and Lin, Hsiao-Yi and Luo, Shue-Fen and Tsai, Shih-Tzu and Tsai, Wen-Chan and Tseng, Jui-Cheng and Wei, Cheng-Chung C and Asavatanabodee, Paijit and Nantiruj, Kanokrat and Nilganuwong, Surasak and Uea-Areewongsa, Parichat and Majstorovic, Ljubinka Bozic and Bacic, Suada Mulic and Batalov, Anastas Z and Georgieva-Slavcheva, Gabriela and Mihailova, Mariyana and Nikolov, Nikolay G and Penev, Dimitar P and Spasov, Yuliy A and Stanimirova, Krasimira and Todorov, Stoyan and Toncheva, Antoaneta R and Yordanova, Nadezhda and Mosterova, Zdenka and Novosad, Libor and Prochazkova, Leona and Stehlikova, Helena and Stejfova, Zuzana and Kiseleva, Natalia and Pank, Lea and Savi, Triin and Alexandra, Balbir-Gurman and Amital, Howard and Mevorach, Dror and Rosner, Itzhak A and Mihailova, Anna and Stumbra-Stumberga, Evija and Basijokiene, Vida and Lietuvininkiene, Virginija and Unikiene, Dalia and Brzezicki, Jan and Dudek, Anna M and Glowacka-Kulesz, Maria B and Grabowicz-Wasko, Barbara and Hajduk-Kubacka, Sabina and Hilt, Joanna and Hrycaj, Pawel and Jeka, Slawomir and Kolasa, Renata and Krogulec, Marek and Mastalerz, Hanna and Olak-Popko, Anna and Owczarek, Elzbieta and Ruzga, Zofia and Walczak, Alina and Ancuta, Codrina I and ... and ORAL Strategy investigators and ORAL Strategy Investigators
The Lancet (British edition), ISSN 0140-6736, 07/2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 12/2014, Volume 120, Issue 23, pp. 3660 - 3668
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2014, Volume 15, Issue 8, pp. 809 - 818
Journal Article